Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?

被引：0
|
作者：
Mieke Carlier
Sofie Carrette
Jason A Roberts
Veronique Stove
Alain Verstraete
Eric Hoste
Pieter Depuydt
Johan Decruyenaere
Jeffrey Lipman
Steven C Wallis
Jan J De Waele
机构：
[1] Microbiology and Immunology &Ghent University,Department of Clinical Chemistry,Department of Critical Care Medicine
[2] Ghent University,Department of Critical Care Medicine
[3] The University of Queensland,Burns Trauma and Critical Care Research Centre
[4] Ghent University Hospital,Department of Laboratory Medicine
[5] Royal Brisbane and Women’s Hospital,undefined
来源：
Critical Care | / 17卷
关键词：
β-lactam antibiotics; hyperfiltration; kidney function; pharmacokinetics; pharmacodynamics; therapeutic drug monitoring;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 24 条
  • [21] Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors
    Gatti, Milo
    Pea, Federico
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (05) : 583 - 599
  • [22] Could an Optimized Joint Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam Be a Valuable Innovative Approach for Maximizing the Effectiveness of Monotherapy Even in the Treatment of Critically Ill Patients with Documented Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Bloodstream Infections and/or Ventilator-Associated Pneumonia?
    Gatti, Milo
    Rinaldi, Matteo
    Tonetti, Tommaso
    Siniscalchi, Antonio
    Viale, Pierluigi
    Pea, Federico
    ANTIBIOTICS-BASEL, 2023, 12 (12):
  • [23] Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem
    Sanz Codina, Maria
    Gatti, Milo
    Troisi, Carla
    Fornaro, Giacomo
    Pasquini, Zeno
    Trapani, Filippo
    Zanoni, Andrea
    Caramelli, Fabio
    Viale, Pierluigi
    Pea, Federico
    PHARMACEUTICS, 2022, 14 (08)
  • [24] Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP
    Gatti, Milo
    Rinaldi, Matteo
    Tonetti, Tommaso
    Siniscalchi, Antonio
    Viale, Pierluigi
    Pea, Federico
    ANTIBIOTICS-BASEL, 2024, 13 (04):
123